Drago Vuina, corporate vice-president of Novo Nordisk Eastern Europe, highlights Poland as the most significant market in the region and the on-going commitment to make innovative treatment options available for patients. Furthermore, he discusses Novo Nordisk’s strong commitment to social responsibility in each country throughout the region and the need to be an active player and integral part of the domestic community.
As the corporate vice-president of Eastern Europe, what is your mandate?
"We built on our responsibility to explain to key stakeholders the benefits of considering the long-term perspective of healthcare, and in this regard, we have been successful in majority of our countries in this region."
